Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

CENTRIENT PHARMACEUTICALS LLC

Filed by AKIN GUMP STRAUSS HAUER & FELD.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 20, 2026
Income
$80,000.00
Expenses
Not reported
Filing UUID
1ef4984a-c029-4747-905d-047bf01f5dec
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

PHA · Pharmacy

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

MAN · Manufacturing

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

DEF · Defense

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States; Issues related to the Defense Production Act (P.L. 81-774).

BUD · Budget/Appropriations

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

TRD · Trade (domestic/foreign)

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.